International progress in cancer gene therapy.
We overview the current status and most recent developments in the field of cancer gene therapy from an international viewpoint. We have largely based our review on presentations from the eighth annual meeting of the International Society for Cell and Gene Therapy of Cancer held in Mumbai, India (www.iscgt.com and www.iscgtindia.com). This has afforded us with the opportunity to describe the most recently published and unpublished data in the field of cancer gene therapy, gaining an insight into the priorities in this field today. In doing so, we hope to have provided a state of the art review of cancer gene therapy, with the help of some of the best-known researchers in the field. In addition, due to the location of the meeting, we had a unique opportunity to listen to some of the seminal cancer gene therapy work being performed in India at this time.
Guinn
B A
BA
Department of Haematological Medicine, King's College London School of Medicine, The Rayne Institute, London, UK. barbara.guinn@kcl.ac.uk
Mulherkar
R
R
D000818:Animals; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy; D007194:India; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D050504:Oncolytic Viruses / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism
D034741:RNA, Small Interfering